Beauty Health (SKIN) Set to Announce Earnings on Thursday

Beauty Health (NASDAQ:SKIN) will likely be posting its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Beauty Health to post earnings of ($1.3350) per share and revenue of $67.97 million for the quarter. Interested persons may review the information on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.40) earnings per share for the quarter, topping the consensus estimate of ($0.50) by $0.10. The business had revenue of $72.11 million during the quarter, compared to analysts’ expectations of $74.45 million. Beauty Health had a negative return on equity of 47.83% and a negative net margin of 9.79%. On average, analysts expect Beauty Health to post ($3.18) EPS for the current fiscal year and ($1.16) EPS for the next fiscal year.

Beauty Health Price Performance

Shares of SKIN stock opened at $10.38 on Tuesday. The company has a debt-to-equity ratio of 4.36, a quick ratio of 1.48 and a current ratio of 1.76. Beauty Health has a fifty-two week low of $9.68 and a fifty-two week high of $34.80. The firm has a market cap of $67.54 million, a P/E ratio of -2.36 and a beta of 1.05. The business’s 50 day moving average price is $12.43 and its 200-day moving average price is $16.75.

Wall Street Analyst Weigh In

A number of analysts recently commented on SKIN shares. TD Cowen assumed coverage on Beauty Health in a research note on Friday. They issued a “hold” rating for the company. Jefferies Financial Group reiterated a “hold” rating and issued a $11.00 price target (up from $0.85) on shares of Beauty Health in a report on Monday, October 19th. Zacks Research downgraded shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. Citigroup restated a “hold” rating on shares of Beauty Health in a report on Thursday, October 15th. Finally, Canaccord Genuity Group set a $11.00 price objective on shares of Beauty Health and gave the stock a “hold” rating in a report on Thursday, October 22nd. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $18.00.

Beauty Health Company Profile

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.